Health
Improving human health and wellbeing
SRI has been a leader for decades in the development of tools, technologies, and therapeutics that have saved and improved countless lives around the world. Our Biosciences division works with government and commercial clients to seamlessly integrate basic and translational research, drug discovery, and nonclinical and clinical development.
Addressing the toughest healthcare problems means working collaboratively. With our expertise in AI, robotics, education & learning, and other fields and disciplines, we do pioneering work areas that include AI-powered platforms for drug discovery, telerobotic surgery, robotics and tele-manipulation for health care applications, diagnostics and sensing, adolescent mental health, and more.
Innovating in
Real-world impact
-
SRI earns FDA Orphan Drug Designation for pancreatic cancer
The designation accelerates clinical development of SRI’s TALL® immunotherapy and brings more affordable therapies to market faster.
-
SRI works with N4 Pharma to target and treat cells in the human body that had been unreachable
Paving the way for targeted treatments, the collaboration aims to help realize the full potential of precision healthcare.
-
Carol Green: Helping new drugs make the leap from possible to practical
Leading the effort to make sure effective therapies progress to human trials.